<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>05944756584467</udiDi>
    <basicUdiDi>B-05944756584467</basicUdiDi>
    <tradeName>DACRIL</tradeName>
    <deviceName>DACRIL</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020101</emdnCode>
    <emdnDescription>POLYGLYCOLIC ACID MULTIFILAMENT WITH NEEDLE FOR OPEN SURGERY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX108</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-08-02T22:37:39.065Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756579999</udiDi>
    <basicUdiDi>B-05944756579999</basicUdiDi>
    <tradeName>DACRIL</tradeName>
    <deviceName>DACRIL</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020103</emdnCode>
    <emdnDescription>POLYGLYCOLIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX125</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-08-02T22:37:37.459Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756579982</udiDi>
    <basicUdiDi>B-05944756579982</basicUdiDi>
    <tradeName>DACRIL</tradeName>
    <deviceName>DACRIL</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020101</emdnCode>
    <emdnDescription>POLYGLYCOLIC ACID MULTIFILAMENT WITH NEEDLE FOR OPEN SURGERY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX124</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-08-02T22:37:35.160Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756579975</udiDi>
    <basicUdiDi>B-05944756579975</basicUdiDi>
    <tradeName>DACRIL</tradeName>
    <deviceName>DACRIL</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020103</emdnCode>
    <emdnDescription>POLYGLYCOLIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX122</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-08-02T22:37:32.655Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756579968</udiDi>
    <basicUdiDi>B-05944756579968</basicUdiDi>
    <tradeName>DACRIL</tradeName>
    <deviceName>DACRIL</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020103</emdnCode>
    <emdnDescription>POLYGLYCOLIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX121</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-08-02T22:37:31.853Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756579951</udiDi>
    <basicUdiDi>B-05944756579951</basicUdiDi>
    <tradeName>DACRIL</tradeName>
    <deviceName>DACRIL</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020103</emdnCode>
    <emdnDescription>POLYGLYCOLIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX117</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-08-02T22:37:30.250Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756579944</udiDi>
    <basicUdiDi>B-05944756579944</basicUdiDi>
    <tradeName>DACRIL</tradeName>
    <deviceName>DACRIL</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020103</emdnCode>
    <emdnDescription>POLYGLYCOLIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX116</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-08-02T22:37:27.857Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756579937</udiDi>
    <basicUdiDi>B-05944756579937</basicUdiDi>
    <tradeName>DACRIL</tradeName>
    <deviceName>DACRIL</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020101</emdnCode>
    <emdnDescription>POLYGLYCOLIC ACID MULTIFILAMENT WITH NEEDLE FOR OPEN SURGERY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX114</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-08-02T22:37:26.254Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756579920</udiDi>
    <basicUdiDi>B-05944756579920</basicUdiDi>
    <tradeName>DACRIL</tradeName>
    <deviceName>DACRIL</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020103</emdnCode>
    <emdnDescription>POLYGLYCOLIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX112</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-08-02T22:37:25.455Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756579913</udiDi>
    <basicUdiDi>B-05944756579913</basicUdiDi>
    <tradeName>DACRIL</tradeName>
    <deviceName>DACRIL</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020103</emdnCode>
    <emdnDescription>POLYGLYCOLIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX111</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-08-02T22:37:23.865Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756579906</udiDi>
    <basicUdiDi>B-05944756579906</basicUdiDi>
    <tradeName>DACRIL</tradeName>
    <deviceName>DACRIL</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020103</emdnCode>
    <emdnDescription>POLYGLYCOLIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX110</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-08-02T22:37:21.452Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756579883</udiDi>
    <basicUdiDi>B-05944756579883</basicUdiDi>
    <tradeName>DACRIL</tradeName>
    <deviceName>DACRIL</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020103</emdnCode>
    <emdnDescription>POLYGLYCOLIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX106</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-08-02T22:37:19.853Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756579876</udiDi>
    <basicUdiDi>B-05944756579876</basicUdiDi>
    <tradeName>DACRIL</tradeName>
    <deviceName>DACRIL</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020103</emdnCode>
    <emdnDescription>POLYGLYCOLIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX105</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-08-02T22:37:19.048Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756579869</udiDi>
    <basicUdiDi>B-05944756579869</basicUdiDi>
    <tradeName>DACRIL</tradeName>
    <deviceName>DACRIL</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020101</emdnCode>
    <emdnDescription>POLYGLYCOLIC ACID MULTIFILAMENT WITH NEEDLE FOR OPEN SURGERY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX104U</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-08-02T22:37:17.581Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756579845</udiDi>
    <basicUdiDi>B-05944756579845</basicUdiDi>
    <tradeName>DACRIL</tradeName>
    <deviceName>DACRIL</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020103</emdnCode>
    <emdnDescription>POLYGLYCOLIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX102</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-08-02T22:37:14.295Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756579838</udiDi>
    <basicUdiDi>B-05944756579838</basicUdiDi>
    <tradeName>DACRIL</tradeName>
    <deviceName>DACRIL</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020103</emdnCode>
    <emdnDescription>POLYGLYCOLIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX101</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-08-02T22:37:12.642Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756579777</udiDi>
    <basicUdiDi>B-05944756579777</basicUdiDi>
    <tradeName>DACRIL</tradeName>
    <deviceName>DACRIL</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020103</emdnCode>
    <emdnDescription>POLYGLYCOLIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX115</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-08-02T22:37:11.887Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756579692</udiDi>
    <basicUdiDi>B-05944756579692</basicUdiDi>
    <tradeName>DACRIL</tradeName>
    <deviceName>DACRIL</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020101</emdnCode>
    <emdnDescription>POLYGLYCOLIC ACID MULTIFILAMENT WITH NEEDLE FOR OPEN SURGERY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX123</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-08-02T22:37:10.256Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756579654</udiDi>
    <basicUdiDi>B-05944756579654</basicUdiDi>
    <tradeName>DACRIL</tradeName>
    <deviceName>DACRIL</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020103</emdnCode>
    <emdnDescription>POLYGLYCOLIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX107</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-08-02T22:37:07.852Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756579579</udiDi>
    <basicUdiDi>B-05944756579579</basicUdiDi>
    <tradeName>DACRIL</tradeName>
    <deviceName>DACRIL</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020101</emdnCode>
    <emdnDescription>POLYGLYCOLIC ACID MULTIFILAMENT WITH NEEDLE FOR OPEN SURGERY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX113</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-08-02T22:37:06.285Z</lastUpdated>
  </row>
</eudamedExport>